Key result
Carbachol interferes with beta-1 receptor actions by reducing cAMP accumulation, whereas its anti-beta-2 receptor actions involve an M2-muscarinic receptor coupled to a pertussis toxin-sensitive G protein.
Why the study?
Does carbachol alter intracellular cAMP accumulation and contractile function in neonatal rat ventricular myocytes stimulated with beta-adrenergic agonists?
Does carbachol alter intracellular cAMP accumulation and contractile function in neonatal rat ventricular myocytes stimulated with beta-adrenergic agonists?
Answers are grounded in this paper and cite their sources.
Muscarinic accentuated antagonism of beta-adrenergic responses in neonatal rat ventricular myocytes occurs via distinct mechanisms for beta 1 (cAMP reduction) and beta 2 (M2-receptor/pertussis toxin-sensitive pathway inhibiting phosphorylation) receptors.
Neonatal rat ventricular myocytes express both beta 1-and beta 2-adrenergic receptors linked to enhanced intracellular adenosine 3',5'-cyclic monophosphate (cAMP) accumulation and the modulation of contractile function. This study tests the hypothesis that muscarinic agonists act via distinct mechanisms to interfere with beta 1-and beta 2-adrenergic receptor actions. The beta 2-selective agonist zinterol (10(-7) M) elicits approximately a fourfold increase in cAMP accumulation, which is mimicked, both in magnitude and kinetics, by 10(-9) M of the mixed beta 1-receptor agonist/beta 2-receptor agonist isoproterenol. At these concentrations, isoproterenol and zinterol elicit equivalent inotropic and lusitropic (i.e., enhanced relaxation) responses. Carbachol inhibits all three responses (cAMP, inotropic, and lusitropic) elicited by isoproterenol. In contrast, carbachol does not interfere with the effect of zinterol to augment cAMP accumulation or to induce a positive inotropic response. However, carbachol inhibits the lusitropic response to zinterol via an action at an M2-muscarinic receptor linked to a pertussis toxin-sensitive pathway. Additional studies indicate that beta 2-receptor-dependent phosphorylation of troponin I and phospholamban is substantially attenuated by carbachol. We conclude that carbachol interferes with beta 1-receptor actions by reducing cAMP accumulation. In contrast, the anti-beta 2-receptor actions of carbachol are mediated by a mechanism that is distinct from inhibition of cAMP accumulation, involving an M2-muscarinic receptor coupled to a pertussis toxin-sensitive G protein, which leads to inhibition of troponin I and phospholamban phosphorylation and inhibition of the beta 2-receptor-dependent lusitropic response.
No takes yet. Share an insight, caveat, or question.
Aprigliano et al. (1997) studied this question. Carbachol vs. Isoproterenol and zinterol alone was evaluated on cAMP accumulation, inotropic, and lusitropic responses. Carbachol interferes with beta-1 receptor actions by reducing cAMP accumulation, whereas its anti-beta-2 receptor actions involve an M2-muscarinic receptor coupled to a pertussis toxin-sensitive G protein.
Synapse has enriched 10 related papers. Consider them for comparative context: